Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Pathogenesis of immunoglobulin A nephropathy.

Novak J, Renfrow MB, Gharavi AG, Julian BA.

Curr Opin Nephrol Hypertens. 2013 May;22(3):287-94. doi: 10.1097/MNH.0b013e32835fef54.

PMID:
23511518
[PubMed - in process]
2.

Glycosylation of IgA1 and pathogenesis of IgA nephropathy.

Novak J, Julian BA, Mestecky J, Renfrow MB.

Semin Immunopathol. 2012 May;34(3):365-82. doi: 10.1007/s00281-012-0306-z. Epub 2012 Mar 21. Review.

PMID:
22434325
[PubMed - indexed for MEDLINE]
3.

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease.

Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.

J Immunol Res. 2014;2014:197548. Epub 2014 Jul 23. Review.

PMID:
25152896
[PubMed - as supplied by publisher]
Free PMC Article
4.

[Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].

Segarra A.

Nefrologia. 2010;30(5):501-7. doi: 10.3265/Nefrologia.pre2010.Jul.10526. Review. Spanish.

PMID:
20882091
[PubMed - indexed for MEDLINE]
Free Article
5.

IgA nephropathy: an update.

Julian BA, Novak J.

Curr Opin Nephrol Hypertens. 2004 Mar;13(2):171-9. Review.

PMID:
15202611
[PubMed - indexed for MEDLINE]
6.

IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.

Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.

Contrib Nephrol. 2007;157:134-8. Review.

PMID:
17495451
[PubMed - indexed for MEDLINE]
7.

The pathophysiology of IgA nephropathy.

Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA.

J Am Soc Nephrol. 2011 Oct;22(10):1795-803. doi: 10.1681/ASN.2011050464. Epub 2011 Sep 23. Review.

PMID:
21949093
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].

Xie L, Wang L, Huang J, Fan J.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb;27(1):227-30. Review. Chinese.

PMID:
20337060
[PubMed - indexed for MEDLINE]
9.

Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.

Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.

J Proteomics. 2013 Oct 30;92:299-312. doi: 10.1016/j.jprot.2013.07.013. Epub 2013 Jul 24.

PMID:
23891555
[PubMed - indexed for MEDLINE]
10.

Biomarkers in IgA nephropathy: relationship to pathogenetic hits.

Hastings MC, Moldoveanu Z, Suzuki H, Berthoux F, Julian BA, Sanders JT, Renfrow MB, Novak J, Wyatt RJ.

Expert Opin Med Diagn. 2013 Nov;7(6):615-27. doi: 10.1517/17530059.2013.856878. Review.

PMID:
24175678
[PubMed - indexed for MEDLINE]
11.

Progress in molecular and genetic studies of IgA nephropathy.

Novak J, Julian BA, Tomana M, Mesteck J.

J Clin Immunol. 2001 Sep;21(5):310-27. Review.

PMID:
11720004
[PubMed - indexed for MEDLINE]
12.

Pathogenesis of IgA nephropathy.

Lai KN.

Nat Rev Nephrol. 2012 Mar 20;8(5):275-83. doi: 10.1038/nrneph.2012.58. Review.

PMID:
22430056
[PubMed - indexed for MEDLINE]
13.

IgA nephropathy: molecular mechanisms of the disease.

Mestecky J, Raska M, Julian BA, Gharavi AG, Renfrow MB, Moldoveanu Z, Novak L, Matousovic K, Novak J.

Annu Rev Pathol. 2013 Jan 24;8:217-40. doi: 10.1146/annurev-pathol-011110-130216. Epub 2012 Oct 18. Review.

PMID:
23092188
[PubMed - indexed for MEDLINE]
14.

The pathogenesis of IgA nephropathy.

Glassock RJ.

Curr Opin Nephrol Hypertens. 2011 Mar;20(2):153-60. doi: 10.1097/MNH.0b013e3283436f5c. Review.

PMID:
21301336
[PubMed - indexed for MEDLINE]
15.

Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.

Narita I, Gejyo F.

Clin Exp Nephrol. 2008 Oct;12(5):332-8. doi: 10.1007/s10157-008-0054-5. Epub 2008 Apr 12. Review.

PMID:
18404247
[PubMed - indexed for MEDLINE]
16.

Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.

Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.

Kidney Blood Press Res. 2008;31(1):29-37. doi: 10.1159/000112922. Epub 2008 Jan 8. Review.

PMID:
18182777
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura.

Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, Lee JY, Huang WQ, Mestecky J, Novak J.

Pediatr Nephrol. 2007 Dec;22(12):2067-72. Epub 2007 Oct 18.

PMID:
17943324
[PubMed - indexed for MEDLINE]
18.

The genetics of IgA nephropathy.

Beerman I, Novak J, Wyatt RJ, Julian BA, Gharavi AG.

Nat Clin Pract Nephrol. 2007 Jun;3(6):325-38. Review.

PMID:
17525715
[PubMed - indexed for MEDLINE]
19.

The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.

Barratt J, Smith AC, Feehally J.

Nephrology (Carlton). 2007 Jun;12(3):275-84. Review.

PMID:
17498123
[PubMed - indexed for MEDLINE]
20.

Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.

Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.

J Clin Invest. 1999 Jul;104(1):73-81.

PMID:
10393701
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk